Results 61 to 70 of about 16,555 (220)

The Effect of Rabeprazole on Injection Sclerotherapy Complications after First Attack Bleeding Esophageal Varices [PDF]

open access: yesAfro-Egyptian Journal of Infectious and Endemic Diseases, 2014
Background and study aim : Endoscopic variceal sclerotherapy (EVS) effectively controls bleeding esophageal varices (OV), however it has some adverse effects including sclerosant ulcers, chest pain, dysphagia and odynophagia. Gastric acid plays a central
Ashraf Metwally   +2 more
doaj   +1 more source

Esophageal Stricture Post Endoscopic Injection Sclerotherapy [PDF]

open access: yes, 2011
Background: Post endoscopic sclerotherapy esophageal stricture is usually not fatal but may requires several sessions of esophageal dilation as an effective palliative treatment yet has its own complications.Aim: The purpose of this study is to find out ...
HKO Ba, Ba, HKO, MO Gadour, Gadour, MO
core   +1 more source

Laparoscopic-assisted sclerotherapy in pediatric retroperitoneal lymphatic malformations

open access: yesFrontiers in Pediatrics
BackgroundRetroperitoneal lymphatic malformations (LMs) are rare. Currently, the treatment of retroperitoneal LMs remains challenging. This study aimed to examine the safety and efficacy of laparoscopic-assisted sclerotherapy for retroperitoneal LMs in ...
Hao Shi   +6 more
doaj   +1 more source

Percutaneous US-guided combined ethanol and tetracycline injection for treating symptomatic simple and hydatid hepatic cysts

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine, 2018
Introduction: Percutaneous treatment of simple or hydatid liver cysts is widely used in clinical practice and ethanol is the commonest sclerosant used.
Ahmed M. Abd El-Khalek   +9 more
doaj   +1 more source

Pink Polypoid Papulo‐Vesicles on Labia Majora

open access: yes
JEADV Clinical Practice, EarlyView.
Maria Chiara Mercuri   +3 more
wiley   +1 more source

Recent Development of Endo‐hepatology

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Endo‐hepatology is a rapidly evolving field encompassing endoscopic diagnosis and treatment of hepatobiliary diseases, primarily using endoscopic ultrasound (EUS). Since its conceptualization in 2012, the field has expanded dramatically alongside advances in interventional EUS. A landmark 2024 review broadened the concept to include endoscopic
Akira Yamamiya   +3 more
wiley   +1 more source

The Treatment Effects of Percutaneous Drainage with or without Sclerotherapy for Symptomatic Liver Cysts

open access: yesGastrointestinal Disorders
Background: While the current guidelines recommend laparoscopic deroofing for symptomatic simple liver cysts, percutaneous drainage may serve as a less invasive alternative method.
Satoshi Takakusagi   +11 more
doaj   +1 more source

Foam Sclerotherapy for Cyst Volume Reduction in Autosomal Dominant Polycystic Kidney Disease: A Prospective Cohort Study

open access: yesKidney Medicine, 2019
Rationale & Objective: Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disorder. Progressive increase in cyst number and size leads to kidney failure in a majority of patients.
Ioan-Andrei Iliuta   +9 more
doaj   +1 more source

A PROSPECTIVE RANDOMIZED STUDY ON THE RISK OF BACTEREMIA IN BANDING VERSUS SCLEROTHERAPY OF ESOPHAGEAL VARICES

open access: yesFrontiers in Medicine, 2016
Background: Esophageal variceal banding may be less likely to cause bacteremia than sclerotherapy. The existing data about the frequency of bacteremia after esophageal variceal banding are conflicting, and few studies include both banding and ...
Marc J Zuckerman   +8 more
doaj   +1 more source

Intralesional sclerotherapy with bleomycin in lymphatic malformation of tongue an institutional experience and outcomes

open access: yesJournal of Indian Association of Pediatric Surgeons, 2020
Introduction: The management of lymphatic malformations (LMs) continues to improve with advancement in molecular genetics, imaging, and treatment options.
Gaurav Parashar   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy